2-(5-phenoxypentyl)-1H-isoindole-1,3(2H)-dione | 101890-49-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 2-(5-phenoxypentyl)-1H-isoindole-1,3(2H)-dione
• 英文别名: 2-(5-phenoxypentyl)isoindoline-1,3-dione；N-(5-phenoxy-pentyl)-phthalimide；N-(5-Phenoxy-pentyl)-phthalimid；2-(5-Phenoxypentyl)isoindole-1,3-dione
• CAS: 101890-49-7
• 化学式: C₁₉H₁₉NO₃
• 分子量: 309.365
• InChiKey: XHUZBWUNHJZIHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  23
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(5-phenoxypentyl)-1H-isoindole-1,3(2H)-dione 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 4.0h， 生成 5-phenoxypentylamine
  参考文献：
  名称：

  Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation

  摘要：

  A series of 9-N-substituted berberine derivatives were synthesized and biologically evaluated as antioxidant and inhibitors of acetylcholinesterase (AChE), butyrylcholinesterase and amyloid-beta aggregation. Most of these compounds exhibited very good antioxidant activities, inhibitive activities of AChE and amyloid-beta aggregation. Among them, compound 8d, (o-methylphenethyl)amino linked at the 9-position of berberine, was found to be a good antioxidant (with 4.05 mu M of Trolox equivalents), potent inhibitor of AChE (an IC50 value of 0.027 mu M), and high active inhibitor of amyloid-beta aggregation (an IC50 value of 2.73 mu M). (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.09.051
• 作为产物：
  描述：

  邻苯二甲酸亚胺 在 苄基三乙基氯化铵 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 24.0h， 生成 2-(5-phenoxypentyl)-1H-isoindole-1,3(2H)-dione
  参考文献：
  名称：

  Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation

  摘要：

  A series of 9-N-substituted berberine derivatives were synthesized and biologically evaluated as antioxidant and inhibitors of acetylcholinesterase (AChE), butyrylcholinesterase and amyloid-beta aggregation. Most of these compounds exhibited very good antioxidant activities, inhibitive activities of AChE and amyloid-beta aggregation. Among them, compound 8d, (o-methylphenethyl)amino linked at the 9-position of berberine, was found to be a good antioxidant (with 4.05 mu M of Trolox equivalents), potent inhibitor of AChE (an IC50 value of 0.027 mu M), and high active inhibitor of amyloid-beta aggregation (an IC50 value of 2.73 mu M). (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.09.051

文献信息

• New N-(phenoxydecyl)phthalimide derivatives displaying potent inhibition activity towards α-glucosidase
  作者：Rossana Pascale、Alessia Carocci、Alessia Catalano、Giovanni Lentini、Anna Spagnoletta、Maria Maddalena Cavalluzzi、Francesco De Santis、Annalisa De Palma、Vito Scalera、Carlo Franchini

  DOI：10.1016/j.bmc.2010.06.088

  日期：2010.8

  Several members of a new family of non-sugar-type α-glucosidase inhibitors, bearing a phthalimide moiety connected to a variously substituted phenoxy ring by an alkyl chain, were synthesized and their activities were investigated. The efficacy of the inhibition activity appeared to be governed by the chain length of the substrate. Substrates possessing 10 carbons afforded the highest levels of activity

  合成了一个新的非糖型α-葡萄糖苷酶抑制剂家族的成员，这些抑制剂带有通过烷基链连接到各种取代的苯氧基环上的邻苯二甲酰亚胺部分，并研究了它们的活性。抑制活性的功效似乎由底物的链长决定。具有10个碳原子的底物具有最高水平的活性，其活性比已知的抑制剂1-脱氧野oji霉素（dNM）强一到两个数量级。此外，结构与活性之间的关系研究表明，苯氧基上的吸电子取代基对于该活性起着至关重要的作用。该系列中最有效的衍生物是带有氯原子以及强吸电子基团（例如硝基）的衍生物。
• Amines
  申请人：MAY &

  公开号：US02830008A1

  公开（公告）日：1958-04-08
• Manasse, Chemische Berichte, 1902, vol. 35, p. 1371
  作者：Manasse

  DOI：——

  日期：——
• AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS
  申请人：SMITHKLINE BEECHAM PLC

  公开号：EP0840725A1

  公开（公告）日：1998-05-13
• [EN] AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS<br/>[FR] DERIVES DE L'AZETIDINONE POUR LE TRAITEMENT DE L'ATHEROSCLEROSE
  申请人：SMITHKLINE BEECHAM PLC

  公开号：WO1997002242A1

  公开（公告）日：1997-01-23

  (EN) Azetidinone compounds of formule (I) in which: R1 and R2, which may be the same or different, is each selected from hydrogen, halogen or C(1-8)alkyl; R4 and R5 which may be the same or different is each selected from hydrogen, C(1-6)alkyl, C(2-6)alkenyl, aryl, aryl(C1-4)alkyl and heteroaryl(C1-4)alkyl each of which may be optionally substituted or R4 and R5 may be linked together to form the remainder of a (C3-7)cycloalkyl ring; X is a linker group; Y is an optionally substituted aryl group; Z is oxygen and R3 is C(1-8)alkyl, C(3-8)cycloalkyl, C(3-8)cycloalkylC(1-6)alkyl, heteroaryl, heteroaryl(C1-4)alkyl, aryl, or aryl(C1-4)alkyl, each of which may be optionally substituted or Z is S(O)n in which n is 0, 1 or 2 and R3 is C(1-8)alkyl, C(3-8)cycloalkyl, C(3-8)cycloalkylC(1-6)alkyl, aryl, aryl(C1-4)alkyl, heteroaryl, or heteroaryl(C1-4)alkyl, each of which may be optionally substituted are inhibitors of the enzyme Lp PLA2 and are of use in therapy, in particular treating atherosclerosis.(FR) L'invention concerne les composés de l'azétidinone présentant la formule (I). Dans cette formule, R1 et R2 peuvent être identiques ou différents, et sont chacun sélectionnés parmi de l'hydrogène, de l'halogène ou de l'alkyle (C1-8); R4 et R5 peuvent être semblables ou différents et sont chacun sélectionnés parmi de l'hydrogène, de l'alkyle (C1-6), de l'alcényle (C2-6), de l'aryle, de l'arylalkyle (C1-4) et de l'hétéroarylalkyle (C1-4), qui peuvent être tous éventuellement substitués, ou R4 et R5 peuvent être liés ensemble pour former le reste d'un noyau de cycloalkyle (C3-7); X est un groupe de liaison; Y est un groupe aryle éventuellement substitué; Z est de l'oxygène et R3 est de l'alkyle (C1-8), du cycloalkyle (C3-8), du cycloalkyle(C3-8)alkyle(C1-6), de l'hétéroaryle, de l'hétéroarylalkyle (C1-4), de l'aryle, ou de l'arylalkyle (C1-4) qui peuvent être tous éventuellement substitués, ou Z désigne à S(O)n où n vaut 0, 1 ou 2 et R3 est de l'alkyle (C1-8), du cycloalkyle (C3-8), du cycloalkyle (C3-8), de l'aryle, de l'alkyle (C1-4) d'aryle, de l'hétéroaryle, ou de l' hétéroarylalkyle (C1-4), qui peuvent tous être éventuellement substitués. Ces composés sont des inhibiteurs de l'enzyme Lp PLA2 et sont particulièrement utiles dans le traitement de l'athérosclérose.